All Pharma articles – Page 4
-
CommentNew regulation will balance safety and innovation
If the UK is to maintain its position as a champion of life sciences, its new regulatory regime must find the middle ground between safety and innovation, notes Lord Ara Darzi
-
Expert BriefingNorth by North West: The tough questions NHSE must answer over famous cancer trust
Essential insight into NHS matters in the North West of England. Contact me in confidence here.
-
News‘Suboptimal’ relationship between NHS and pharma needs ‘urgent’ attention, says ex-NICE chief
The relationship between the NHS and the pharmaceutical sector is ‘suboptimal’ because of the misalignment of ‘ambitions, constraints and risk appetites’, according to former National Institute for Health and Care Excellence Sir Andrew Dillon.
-
HSJ LocalMultiple failings in trust’s handling of £20m Roche deal, leak reveals
Multiple failings have been identified in how a leading cancer trust entered into a £20m research partnership with a large pharmaceutical company, and how bosses then reacted to concerns raised by staff.
-
NewsCovid vaccine will be rolled out at ‘60pc of optimum capacity’ during first week
The covid-19 vaccine will be delivered at almost half of planned capacity when the vaccination programme is rolled out tomorrow, according to new national guidance.
-
NewsNHS England reveals community pharmacies’ role in covid vax effort
Selected community pharmacies will provide up to 1,000 coronavirus vaccines each week, in addition to those provided by general practice and mass centres, according to an NHS England letter.
-
NewsExclusive: NHS setting up dozens of mass covid vaccination centres and seeking 40,000 staff
The health service is setting up more than 40 mass vaccination centres, and working on recruiting tens of thousands of staff for the huge covid-19 vaccination effort, HSJ has learned.
-
NewsLeaked government review plans new law to push data sharing
An official review carried out for the health secretary, leaked to HSJ, reveals plans to bolster the law to require greater sharing of patient data, saying it would help improve safety for those wrongly prescribed drugs.
-
NewsExclusive: Stevens accuses drugs firm of ‘using cover of coronavirus to price-gouge taxpayers’
The NHS England chief executive has publicly accused a pharma company of ”using the cover of coronavirus to try and price-gouge British taxpayers” — a claim the firm has strongly denied.
-
HSJ AwardsHSJ Value Awards 2020: Pharmacy and Medicines Optimisation Award
Winner The Great North Children’s Hospital, The Newcastle upon Tyne Hospitals Foundation Trust: The Kidzmed project - teaching children to swallow tablet medication The Kidzmed project was a quality improvement project to teach children and young people how to take tablet medication. Tablets are safer, more convenient and cheaper than ...
-
HSJ PartnersWe need to hear the voices of healthcare professionals on how we change the ABPI Code of Practice
The Association of the British Pharmaceutical Industry is consulting on its proposed Code of Practice for 2021, which supports industry to operate in a professional, ethical and transparent manner. ABPI president Haseeb Ahmad explains how healthcare professionals come into contact with the Code, so it is important to contribute their ...
-
NewsExclusive: Government delay could see people miss out on vaccines
Pharmacies are warning people are at risk of not getting the flu jab unless an urgent decision is made over the winter vaccination programme.
-
NewsNHS warned it ‘will not be forgiven’ if it fails to act on Cumberlege report
The government and healthcare system “will not be forgiven” if they fail to act on a major report which reveals “institutional” resistance in the NHS to patient safety concerns, its authors warned today.
-
News
All doctors’ financial interests must be published
A government review says the financial interests of all doctors should be published on the General Medical Council’s register, due to concerns around potential conflicts of interest.
-
NewsThe NHS is failing ‘all those it was set up to serve’, concludes government review
The NHS has “either lost sight of the interests of all those it was set up to serve or does not know how best to do this”, a major government-commissioned review has concluded.
-
NewsWebinar: how covid sparked unprecedented collaboration between the NHS and industry
The need to respond at scale and pace to the coronavirus pandemic has created unprecedented collaboration between the NHS and the pharmaceutical and medical devices sector.
-
NewsGovernment spent at least £5m on drug championed by Trump
The Department for Health and Social Care paid at least £3.15m on a bulk order of hydroxychloroquine tablets in April for clinical trials, after reportedly spending £2m on the drug in March.
-
HSJ KnowledgeGenomics and precision medicine in oncology
At an HSJ and Bayer roundtable experts discussed how NHS leaders can get to grips with genomics and precision medicine – and how we can ensure that every oncology patient who will benefit will have access to these developing technologies
-
NewsNHS could have ‘answers’ on new covid treatments ‘before end of June’
The first results of clinical trials into therapeutic drugs used to treat covid-19 patients could be available before the end of June, according to an NHS letter.
-
HSJ PartnersCovid-19: using digital services and data to fight the pandemic
Coronavirus presents the biggest challenge to the NHS in its 70-year history. Written by As the UK’s leading provider of connected healthcare software and systems – supporting 10,000 healthcare organisations – EMIS Group has a critical role to play. In England alone, our systems support 4,000 GP practices, ...